Register entry
- Registered sites
- 0
- Active NDC listings
- 51
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
5151 active NDC listings: 51 human prescription drug. By marketing category: NDA 35, BLA 16.
| Dosage form | NDCs |
|---|---|
| injection | 7 |
| tablet | 7 |
| capsule | 5 |
| injection, solution | 5 |
| tablet, film coated | 5 |
| injection, powder, lyophilized, for solution | 4 |
| kit | 4 |
| capsule, coated pellets | 3 |
| injection, suspension | 3 |
| capsule, gelatin coated | 2 |
| injection, powder, for solution | 2 |
| solution | 2 |
| powder | 1 |
| tablet, for suspension | 1 |
| Route | NDCs |
|---|---|
| oral | 25 |
| intravenous | 13 |
| subcutaneous | 5 |
| intramuscular | 4 |
| intra-articular | 3 |
| intralesional | 1 |
| topical | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| e.r. squibb & sons, l.l.c. | 51 |
Catalogue
Marketed products
51| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| AZACTAM | AZTREONAM | injection, powder, for solution, intramuscular, intravenous | 0003-2560NDA |
| AZACTAM | AZTREONAM | injection, powder, for solution, intramuscular, intravenous | 0003-2570NDA |
| Augtyro | repotrectinib | capsule, oral | 0003-4040NDA |
| Augtyro | repotrectinib | capsule, oral | 0003-4160NDA |
| BARACLUDE | entecavir | tablet, film coated, oral | 0003-1611NDA |
| BARACLUDE | entecavir | tablet, film coated, oral | 0003-1612NDA |
| BARACLUDE | entecavir | solution, oral | 0003-1614NDA |
| Cobenfy | xanomeline and trospium chloride | capsule, coated pellets, oral | 0003-0050NDA |
| Cobenfy | xanomeline and trospium chloride | capsule, coated pellets, oral | 0003-0125NDA |
| Cobenfy | xanomeline and trospium chloride | capsule, coated pellets, oral | 0003-1100NDA |
| Cobenfy | xanomeline and trospium chloride | kit | 0003-5150NDA |
| Cobenfy | xanomeline and trospium chloride | kit | 0003-5200NDA |
| ELIQUIS | apixaban | tablet, film coated, oral | 0003-0893NDA |
| ELIQUIS | apixaban | tablet, film coated, oral | 0003-0894NDA |
| ELIQUIS | apixaban | tablet, for suspension, oral | 0003-1028NDA |
| ELIQUIS 30-Day Starter Pack | apixaban | kit | 0003-3764NDA |
| ELIQUIS 30-Day Starter Pack | apixaban | kit | 0003-3765NDA |
| ELIQUIS SPRINKLE | apixaban | capsule, oral | 0003-0898NDA |
| EMPLICITI | elotuzumab | injection, powder, lyophilized, for solution, intravenous | 0003-2291BLA |
| EMPLICITI | elotuzumab | injection, powder, lyophilized, for solution, intravenous | 0003-4522BLA |
| EVOTAZ | atazanavir and cobicistat | tablet, oral | 0003-3641NDA |
| HALOG | Halcinonide | solution, topical | 0003-0249NDA |
| KENALOG-10 | TRIAMCINOLONE ACETONIDE | injection, suspension, intra-articular, intralesional | 0003-0494NDA |
| KENALOG-40 | TRIAMCINOLONE ACETONIDE | injection, suspension, intra-articular, intramuscular | 0003-0293NDA |
| KENALOG-80 | TRIAMCINOLONE ACETONIDE | injection, suspension, intra-articular, intramuscular | 0003-0315NDA |
| NULOJIX | BELATACEPT | injection, powder, lyophilized, for solution, intravenous | 0003-0371BLA |
| OPDIVO | nivolumab | injection, intravenous | 0003-3734BLA |
| OPDIVO | nivolumab | injection, intravenous | 0003-3756BLA |
| OPDIVO | nivolumab | injection, intravenous | 0003-3772BLA |
| OPDIVO | nivolumab | injection, intravenous | 0003-3774BLA |
| OPDIVO QVANTIG | nivolumab and hyaluronidase-nvhy | injection, solution, subcutaneous | 0003-3120BLA |
| OPDIVO QVANTIG | nivolumab and hyaluronidase-nvhy | injection, solution, subcutaneous | 0003-6120BLA |
| OPDUALAG | nivolumab and relatlimab-rmbw | injection, intravenous | 0003-7125BLA |
| ORENCIA | abatacept | injection, powder, lyophilized, for solution, intravenous | 0003-2187BLA |
| ORENCIA | abatacept | injection, solution, subcutaneous | 0003-2188BLA |
| ORENCIA | abatacept | injection, solution, subcutaneous | 0003-2814BLA |
| ORENCIA | abatacept | injection, solution, subcutaneous | 0003-2818BLA |
| REYATAZ | ATAZANAVIR | capsule, gelatin coated, oral | 0003-3622NDA |
| REYATAZ | ATAZANAVIR | capsule, gelatin coated, oral | 0003-3631NDA |
| REYATAZ | ATAZANAVIR | powder, oral | 0003-3638NDA |
| SOTYKTU | deucravacitinib | tablet, film coated, oral | 0003-0895NDA |
| SPRYCEL | dasatinib | tablet, oral | 0003-0524NDA |
| SPRYCEL | dasatinib | tablet, oral | 0003-0527NDA |
| SPRYCEL | dasatinib | tablet, oral | 0003-0528NDA |
| SPRYCEL | dasatinib | tablet, oral | 0003-0852NDA |
| SPRYCEL | dasatinib | tablet, oral | 0003-0855NDA |
| SPRYCEL | dasatinib | tablet, oral | 0003-0857NDA |
| YERVOY | ipilimumab | injection, intravenous | 0003-2327BLA |
| YERVOY | ipilimumab | injection, intravenous | 0003-2328BLA |
| ZENBEXUS | iberdomide | capsule, oral | 0003-5700NDA |
| ZENBEXUS | iberdomide | capsule, oral | 0003-5710NDA |
Compare
Other companies listing apixaban
- Cardinal Health 418, Inc.34 sites · 833 NDC
- Dr. Reddy's Laboratories Limited15 sites · 683 NDC
- Indoco Remedies Limited7 sites · 58 NDC
- International Medication Systems, Ltd.3 sites · 2,801 NDC
- SK BIOTEK2 sites · 10 NDC
- Proficient Rx LP1 site · 1,729 NDC
- RemedyRepack, Inc1 site · 1,521 NDC
- Aphena Pharma Solutions - Tennessee, LLC0 sites · 795 NDC
- Pharmacia and Upjohn Company LLC0 sites · 148 NDC
- Pfizer Ireland Pharmaceuticals Unlimited Company0 sites · 71 NDC
Enquiry
Common questions
- Is E.R. Squibb & Sons, L.L.C. FDA approved?
- E.R. Squibb & Sons, L.L.C. holds no registered establishment of its own; 51 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does E.R. Squibb & Sons, L.L.C. make?
- 51 products are listed under E.R. Squibb & Sons, L.L.C. in the openFDA NDC Directory, most often as injection; tablet; capsule. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.